Momotaro-Gene
Latest round
- Series B
Last raised
- Mar 2019
Total raised
- $15M
Investors
- 6
About Momotaro-Gene
Based in Okayama-shi, Japan, Momotaro-Gene Inc.Momotaro-Gene Inc. focuses on creating advanced cancer treatment solutions.Momotaro-Gene Inc. specializes in developing innovative cancer therapies that leverage genetic and pharmaceutical combinations to target various tumors. Their primary offerings include a patented combination therapy utilizing the REIC/Dkk-3 gene and checkpoint inhibitors, aimed at enhancing the effectiveness of existing cancer treatments. Additionally, the company is advancing a method for treating liver cancer that combines REIC/Dkk-3 with antitumor agents. These therapies are undergoing clinical trials, including phase I/IIa studies conducted at Okayama University Hospital, specifically targeting malignant gliomas.Momotaro-Gene Inc. generates revenue through strategic partnerships and collaborations within the pharmaceutical industry, particularly focusing on the oncology sector. The company's business model involves agreements with healthcare institutions and pharmaceutical companies for the co-development and commercialization of their therapeutic solutions. Transactions occur through licensing arrangements, where clinical trial results may lead to further investment and support from partners. Revenue is derived from milestones achieved during the drug development process and potential royalties on future sales of successfully marketed therapies.In April 2023, Momotaro-Gene Inc. The firm is focused on advancing its innovative cancer therapies, with plans to expand its reach into new geographical markets beyond Japan as development progresses.
Who invested in Momotaro-Gene
6 investors across 2 rounds
See all investors in Momotaro-Gene
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Momotaro-Gene
Who invested in Momotaro-Gene?
Momotaro-Gene has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Momotaro-Gene raised?
Momotaro-Gene has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Momotaro-Gene last raise money?
Momotaro-Gene's most recent round on record is a Series B, in Mar 2019.
What does Momotaro-Gene do?
Based in Okayama-shi, Japan, Momotaro-Gene Inc.
Where is Momotaro-Gene headquartered?
Momotaro-Gene is headquartered in Okayama-shi, Japan.
Which VCs invest in companies like Momotaro-Gene?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Momotaro-Gene's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Momotaro-Gene? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.